The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli.

TÓM TẮT Đặt vấn đề: Nhiễm Covid-19 đồng thời nhiễm trùng huyết là một bệnh nặng, nguy cơ tử vong cao. Nghiên cứu này nhằm mô tả đặc điểm bệnh nhân Covid-19 nhiễm trùng huyết cấy máu dương tính; đặc điểm vi khuẩn gây nhiễm trùng huyết và mức độ đáp ứng kháng sinh của vi khuẩn trên kháng sinh đồ. Phương pháp nghiên cứu: Mô tả cắt ngang, 26 bệnh nhân Covid-19 cấy máu dương tính từ 8/2021 - 10/2021. Kết quả: 26 bệnh nhân có độ tuổi trung bình 57,89 (nhỏ nhất 32; lớn nhất 78) tuổi, 57,7% bệnh nhân lớn hơn 60 tuổi, nữ nhiều hơn nam, 69,23% bệnh nhân có bệnh nền, thời gian nằm viện trung bình là 16,35 ngày, 84,62% bệnh nhân cấy máu dương tính sau 48 giờ nằm viện, 23,08% bệnh nhân hồi phục sau điều trị. 96,15% bệnh nhân tăng CRP, 100% bệnh nhân tăng Procalcitonin, 86,46% bệnh nhân tăng bạch cầu chung và bạch cầu trung tính. Vi khuẩn gây nhiễm trùng huyết nhiều nhất là Acinetobacter baumannii, Escherichia coli, Burkholderia cepacia với tỷ lệ 19,23% mỗi loại. Vi khuẩn Gram âm nhạy cảm nhiều nhất với nhóm kháng sinh Carbapenem, Aminoglycosid, vi khuẩn Gram dương nhạy cảm nhiều với kháng sinh Linezolid, Vancomycin. Kết luận: Nhiễm trùng huyết trên bệnh nhân Covid làm tăng tỷ lệ tử vong, xác định chủng vi khuẩn và điều trị kháng sinh tích cực phù hợp với từng chủng vi khuẩn là cần thiết. ABSTRACT POSITIVE BLOOD CULTURE SEPSIS IN COVID-19 PATIENTS Background: Infection with Covid 19 and sepsis is a severedisease that leads to a high risk of death. This study aims to describe the characteristics of Covid-19 patients with positive blood culture, elements of bacteria causing sepsis, and the level of antibiotic response of bacteria on the antibiotic chart. Methods: A cross - sectional descriptive study was conducted on 26 Covid-19 patients with positive blood culture 8/2021-10/2021. Result: Twenty - six Covid-19 patients had an average age of 57.89 years (range: 32 - 78). Of these, 57.7% of patients were older than 60 years; women were more than men. 69.23% of patients had a medical history of the disease. The average treatment time was 16.35 days; 84.62% of patients had positive blood cultures after 48 hours of treatment. 23.08% of patients were recovered after treatment. 96.15% of patients increased CRP, 100% of patientsincreased Procalcitonin, and 86.46% increased leukocytosis and neutrophils. The bacteria that caused the most sepsis are Acinetobacter baumannii, Escherichia coli, Burkholderia cepacia with 19.23%. Gram - negative bacteria were most sensitive to Carbapenem, Aminoglycoside antibiotics. Gram - positive bacteria were more susceptible to Linezolid and Vancomycin antibiotics. Conclusion: Sepsis with positive blood culture in covid patients increases the mortality rate. Identifying bacterial strains and appropriate aggressive antibiotic treatment for each bacterial is necessary. Keywords: Sepsis, bacteria, sensitive, Covid-19.

Download Full-text

Faculty Opinions recommendation of Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718131495.793498601 ◽

2014 ◽

Author(s):

Stan Deresinski

Keyword(s):

Blood Culture ◽

Clinical Evaluation ◽

Positive Blood Culture ◽

Identification Of Bacteria ◽

Culture Identification

Download Full-text

Proposal for the use of echocardiography in bloodstream infections due to different streptococcal species

BMC Infectious Diseases ◽

10.1186/s12879-021-06391-2 ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Sandra Chamat-Hedemand ◽

Niels Eske Bruun ◽

Lauge Østergaard ◽

Magnus Arpi ◽

Emil Fosbøl ◽

...

Keyword(s):

Risk Factors ◽

Risk Factor ◽

High Risk ◽

Blood Culture ◽

Positive Blood Culture ◽

Bloodstream Infections ◽

Low Risk ◽

Moderate Risk ◽

Streptococcal Species ◽

Very High

Abstract Background Infective endocarditis (IE) is diagnosed in 7–8% of streptococcal bloodstream infections (BSIs), yet it is unclear when to perform transthoracic (TTE) and transoesophageal echocardiography (TOE) according to different streptococcal species. The aim of this sub-study was to propose a flowchart for the use of echocardiography in streptococcal BSIs. Methods In a population-based setup, we investigated all patients admitted with streptococcal BSIs and crosslinked data with nationwide registries to identify comorbidities and concomitant hospitalization with IE. Streptococcal species were divided in four groups based on the crude risk of being diagnosed with IE (low-risk < 3%, moderate-risk 3–10%, high-risk 10–30% and very high-risk > 30%). Based on number of positive blood culture (BC) bottles and IE risk factors (prosthetic valve, previous IE, native valve disease, and cardiac device), we further stratified cases according to probability of concomitant IE diagnosis to create a flowchart suggesting TTE plus TOE (IE > 10%), TTE (IE 3–10%), or “wait & see” (IE < 3%). Results We included 6393 cases with streptococcal BSIs (mean age 68.1 years [SD 16.2], 52.8% men). BSIs with low-risk streptococci (S. pneumoniae, S. pyogenes, S. intermedius) are not initially recommended echocardiography, unless they have ≥3 positive BC bottles and an IE risk factor. Moderate-risk streptococci (S. agalactiae, S. anginosus, S. constellatus, S. dysgalactiae, S. salivarius, S. thermophilus) are guided to “wait & see” strategy if they neither have a risk factor nor ≥3 positive BC bottles, while a TTE is recommended if they have either ≥3 positive BC bottles or a risk factor. Further, a TTE and TOE are recommended if they present with both. High-risk streptococci (S. mitis/oralis, S. parasanguinis, G. adiacens) are directed to a TTE if they neither have a risk factor nor ≥3 positive BC bottles, but to TTE and TOE if they have either ≥3 positive BC bottles or a risk factor. Very high-risk streptococci (S. gordonii, S. gallolyticus, S. mutans, S. sanguinis) are guided directly to TTE and TOE due to a high baseline IE prevalence. Conclusion In addition to the clinical picture, this flowchart based on streptococcal species, number of positive blood culture bottles, and risk factors, can help guide the use of echocardiography in streptococcal bloodstream infections. Since echocardiography results are not available the findings should be confirmed prospectively with the use of systematic echocardiography.

Download Full-text

649. Clinical Implementation of a Rapid Susceptibility Testing Procedure, Directly From a Positive Blood Culture Using the Vitek®2 System on Gram Negative Rods

Open Forum Infectious Diseases ◽

10.1093/ofid/ofaa439.843 ◽

2020 ◽

Vol 7 (Supplement_1) ◽

pp. S383-S383

Author(s):

Charma Henry ◽

Dustin Evans ◽

Daniel Navas ◽

Arleen Barker ◽

Chonnapat Somyos ◽

...

Keyword(s):

Blood Culture ◽

Positive Blood Culture ◽

Susceptibility Testing ◽

Testing Procedure ◽

Turnaround Time ◽

National Average ◽

Major Error ◽

Clinical Implementation ◽

Salmonella Spp ◽

Gram Negative

Abstract Background The national average of identification and susceptibility for organisms isolated from positive blood culture to final susceptibility based on growth on solid media is 48 hours. The goal of this research was to prove that the Vitek®2 (bioMérieux, Inc.) system can provide an accurate and reliable susceptibility result directly from positive blood culture for Gram negative rods and reduce the turnaround time (TAT) from positive blood culture to the final susceptibility. Methods An FDA-modified validation procedure was performed on positive blood cultures directly from the bottle to the VITEK®2 System for susceptibility testing. The protocol tested and validated an aliquot of 50uL of blood directly from the positive bottle into 10 mL of saline (1:200). The solution was vortexed and 3mL were placed in the VITEK®2 test tube. This protocol was intended only for Gram negative rods using the AST-GN70, AST-GN81 & AST-GN801 cards. This protocol followed the CLSI M52 and M100 guidelines. Results 515 organisms from clinical blood culture samples from July 2018 to October 2019 were evaluated. Organisms included, but were not limited to: E. coli, K. pneumoniae, Enterobacter spp., and P. aeruginosa, Proteus spp., Salmonella spp., Acinetobacter spp., and S. maltophilia. There were 5,201 drug/bug combinations. AdventHealth Orlando achieved an essential agreement of 99.32% (n=5,166), minor error 0.74% (n=39) major error 0.02% (n=1) and very major error 0.49% (n=2). A 100% agreement was achieved on detection of ESBL, CRE, and MDR organisms. Conclusion Rapid direct blood culture protocol using the VITEK®2 System and the AST-GN cards is accurate, reliable and can be performed with less than 1 minute hands-on time. The protocol can be implemented in any laboratory at no additional costs or modification where the current VITEK®2 AST-GN panels are in use. This protocol was clinically implemented at AdventHealth Orlando on July 15, 2019. Compared with the national average of 72 hours, the TAT obtained during this study was 23 hours from positive blood culture to final susceptibility, a significant reduction of 25 hours. The authors encourage bioMérieux Inc. to evaluate and explore the opportunity to expand the use of the VITEK®2 system for this application with the appropriate clinical trial. Disclosures All Authors: No reported disclosures

Download Full-text